Correlation Between China SXT and Esperion Therapeutics
Can any of the company-specific risk be diversified away by investing in both China SXT and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China SXT and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China SXT Pharmaceuticals and Esperion Therapeutics, you can compare the effects of market volatilities on China SXT and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China SXT with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of China SXT and Esperion Therapeutics.
Diversification Opportunities for China SXT and Esperion Therapeutics
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between China and Esperion is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding China SXT Pharmaceuticals and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and China SXT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China SXT Pharmaceuticals are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of China SXT i.e., China SXT and Esperion Therapeutics go up and down completely randomly.
Pair Corralation between China SXT and Esperion Therapeutics
Given the investment horizon of 90 days China SXT Pharmaceuticals is expected to under-perform the Esperion Therapeutics. In addition to that, China SXT is 1.49 times more volatile than Esperion Therapeutics. It trades about -0.04 of its total potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.0 per unit of volatility. If you would invest 633.00 in Esperion Therapeutics on August 28, 2024 and sell it today you would lose (376.00) from holding Esperion Therapeutics or give up 59.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
China SXT Pharmaceuticals vs. Esperion Therapeutics
Performance |
| Timeline |
| China SXT Pharmaceuticals |
| Esperion Therapeutics |
China SXT and Esperion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with China SXT and Esperion Therapeutics
The main advantage of trading using opposite China SXT and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China SXT position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.| China SXT vs. Akanda Corp | China SXT vs. Petros Pharmaceuticals | China SXT vs. GelStat Corp | China SXT vs. Shuttle Pharmaceuticals |
| Esperion Therapeutics vs. Eliem Therapeutics | Esperion Therapeutics vs. HCW Biologics | Esperion Therapeutics vs. Scpharmaceuticals | Esperion Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |